Advanced Search
HUANG Wen-xing, LAI Yi-sheng, ZHANG Yi-hua, WANG Zhen-guo, ZHANG Zhi-hao, MA Lin, JI Hui. Synthesis and anti-inflammatory activity of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives[J]. Journal of China Pharmaceutical University, 2009, 40(6): 497-502.
Citation: HUANG Wen-xing, LAI Yi-sheng, ZHANG Yi-hua, WANG Zhen-guo, ZHANG Zhi-hao, MA Lin, JI Hui. Synthesis and anti-inflammatory activity of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives[J]. Journal of China Pharmaceutical University, 2009, 40(6): 497-502.

Synthesis and anti-inflammatory activity of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives

More Information
  • Aim :To study the synthesis and anti-inflammatory activity of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives. Methods :A series of p-(sulfamyl)benzylidene-linked heterocyclic ketone derivatives were synthesized.Anti-inflammatory activity was evaluated against xylene-induced ear oedema in mice and against carrageenan-induced paw oedema in rats.Gastrointestinal side effects in the rats were also examined after continuous introgastric administration of these compounds once daily for 7 days. Results :Twelve compounds(LHZ-101-LHZ-112)were synthesized and their structures were confirmed by IR,1H NMR,MS and elemental analysis.LHZ-105,LHZ-106 and LHZ-111 exhibited marked anti-inflammatory activity in xylene-induced mice ear swelling model.LHZ-106 and LHZ-111 showed significant anti-inflammatory activity in carrageenan-induced rat paw edema model.LHZ-105,LHZ-106 and LHZ-111 had less gastrointestinal side effects than diclofenac sodium and CI-1004. Conclusion :These results suggest that some of these compounds have the potential for anti-inflammatory activity with few gastrointestinal side effects.
  • Related Articles

    [1]CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217
    [2]WAN Aini, XU Dongsheng, CAI Yanfei, CHEN Yun, JIN Jian, LI Huazhong. Anti-liver fibrosis activities of human insulin-like growth factor-1 in vitro[J]. Journal of China Pharmaceutical University, 2017, 48(4): 476-482. DOI: 10.11665/j.issn.1000-5048.20170413
    [3]Expression and Activity Identification of Shortened Human Acidic Fibroblast Growth Factor[J]. Journal of China Pharmaceutical University, 2004, (5): 84-87.
    [4]Effective Expression and Purification of Human Insulin Like Growth Factor-1 in Bombyx Mori Nuclear Polyhedrosis Virus System[J]. Journal of China Pharmaceutical University, 2004, (2): 76-80.
    [5]Effect of Lovastatin on the Expression of Insulin-like Growth Factor-1 in the Cultured Human Mesangial Cells[J]. Journal of China Pharmaceutical University, 2003, (6): 43-47.
    [6]The Status of Fibroblast Growth Factor Use in the Treatment of Coronary Heart Disease Research[J]. Journal of China Pharmaceutical University, 2003, (3): 89-94.
    [7]Expression of Human Transforming Growth Factor β3 in E.coli BL21[J]. Journal of China Pharmaceutical University, 2003, (3): 70-73.
    [8]Influence of Irbesartan on the Expression of Connective Tissue Growth Factor in Streptozotocin Induced Diabetic Rats[J]. Journal of China Pharmaceutical University, 2002, (4): 64-68.
    [9]Study of Recombinant Human Acidic Fibroblast Growth Factor on Improving Wound Healing in Rabbits[J]. Journal of China Pharmaceutical University, 2002, (4): 50-53.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return